Autopsy report · NCT02011451

Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis

“unable to enroll”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Louisiana State University Health Sciences Center in New Orleans

Sponsor type

University, hospital or other

Conditions

Multiple Sclerosis

Interventions

95% Pure ECGC capsules 200mg; Placebo Comparator:

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Surgical PA-LAA Shunting: a Feasibility Study
  “Failure to enroll” (93% match in meaning)
• Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients
  “Difficulty enrolling” (89% match in meaning)
• Physica System KR Vs Physica System CR (K-20)
  “Problems with enrollement” (88% match in meaning)
• Cervical Ripening in Postmenopausal Women
  “not able to meet enrollment” (88% match in meaning)
• Inferior Vena Cava (IVC) Diameters Before & After Interscalene Block
  “unable to enroll subjects” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.